Triumph Capital Management’s Doximity DOCS Stock Holding History

Triumph Capital Management’s Portfolio DOCS Stock Details DOCS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-200	Closed	-$8.86K	–	1856
2025 Q4	$8.86K	Buy	+200	New	+$11.2K	﹤0.01%	1114

Other funds holding DOCS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Triumph Capital Management's DOCS Position: Q1 2026 in Review

Triumph Capital Management sold out of Doximity (DOCS) in Q1 2026, closing a stake of 200 shares — an estimated $8.86K sold.

Triumph Capital Management first reported a position in DOCS in Q4 2025 and held it in 1 quarter. The position peaked at $8.86K in Q4 2025. 419 funds tracked by Wall St. Rank hold DOCS as of Q1 2026.

Triumph Capital Management reported no remaining Doximity position as of Q1 2026 after selling out during the quarter.
Triumph Capital Management sold 200 Doximity shares in Q1 2026, an estimated $8.86K.
Triumph Capital Management first reported a position in Doximity in Q4 2025 and held it in 1 quarter.
Triumph Capital Management's Doximity position peaked at $8.86K in Q4 2025.
419 funds tracked by Wall St. Rank held Doximity as of Q1 2026.

Based on Triumph Capital Management's 13F filing for Q1 2026, filed 13 May 2026.